Know How Tresiba Compares to Other Basal Insulins for Type 2 Diabetes

September 2017

Reps will raise questions about whether insulin degludec (Tresiba, etc) is better than other basal insulins (Lantus, etc) for type 2 diabetes.

They're sharing new data that suggest insulin degludec U-100 has a lower risk of symptomatic hypoglycemia than insulin glargine U-100.

But help put this in perspective.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Hypertension Watch for Commonly Used Meds and Supplements That May Increase Blood Pressure
Liver Disease Optimize Meds for Comorbidities in Nonalcoholic Fatty Liver Disease
Neurology & Pain Consider Pros and Cons of Meds for Diabetic Peripheral Neuropathy
Women's Health Help Pregnant Women Choose a Prenatal Vitamin
Cannabinoids Explain Risks and Benefits of Medical Marijuana
Dermatology Tell Patients to Think of New Tattoos as Wounds
Multiple Sclerosis Help Patients Manage Side Effects of Multiple Sclerosis Meds
Menopause New Intrarosa Is an Alternative to Vaginal Estrogen for Dyspareunia
Anticoagulants Use a Low-Molecular-Weight Heparin for Most Patients With Cancer-Associated VTE
Insulin Know How Tresiba Compares to Other Basal Insulins for Type 2 Diabetes
Med Safety Be Aware of Standardized Concentrations for Compounded Oral Liquid Medications

Know How Tresiba Compares to Other Basal Insulins for Type 2 Diabetes

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents